Surgical Innovations GroupLSE:SUN OCF Yield % is 12.84 as of Jul. 03, 2026, which is 124% above its 10-year median of 5.74. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Surgical Innovations Group ranks better than 90.4% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Surgical Innovations Group's OCF Yield % or its related term are showing as below:
LSE:SUN'
s OCF Yield % Range Over the Past 10 Years
Min: -3.29 Med: 5.74 Max: 18.43
Current: 12.84
During the past 13 years, the highest OCF Yield % of Surgical Innovations Group was 18.43%. The lowest was -3.29%. And the median was 5.74%.
LSE:SUN's OCF Yield % is ranked better than 90.4% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs LSE:SUN: 12.84
Surgical Innovations Group OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Surgical Innovations Group OCF Yield % Related Terms
Surgical Innovations Group OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surgical Innovations Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Innovations Group OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Surgical Innovations Group's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Innovations Group (LSE:SUN) has a OCF Yield % of 12.84 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Surgical Innovations Group and its competitors. This is 124% above median its historical median of 5.74. According to the industry distribution chart, Surgical Innovations Group ranks #82 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 9.6%.
Is Surgical Innovations Group's OCF Yield % too high?
Surgical Innovations Group's current OCF Yield % of 12.84 is 124% above median its 10-year median of 5.74. The Medical Devices & Instruments industry median OCF Yield % is 1.68. Surgical Innovations Group's value of 12.84 is 664.3% above this industry median. Based on the distribution chart, Surgical Innovations Group ranks #82 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Surgical Innovations Group's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Surgical Innovations Group ranks #82 out of 854 companies for OCF Yield %. This places Surgical Innovations Group in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.68. Surgical Innovations Group's value of 12.84 is 664.3% above this benchmark. While the company's 10-year median is 5.74 vs. the industry median of 1.68, Surgical Innovations Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.68, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Innovations Group's current OCF Yield % of 12.84 is 664.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Surgical Innovations Group and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Innovations Group's current OCF Yield % is 12.84, which is 124% above median its own 10-year median of 5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Based on GuruFocus' analysis, Surgical Innovations Group (LSE:SUN) is currently considered Possible Value Trap. The stock's GF Value™ is £0.01, compared to a current price of £0.00 — trading 52.5% below its estimated fair value. The current OCF Yield % is 12.84, which is 124% above median its 10-year median of 5.74 and 664.3% above the Medical Devices & Instruments industry median of 1.68. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current OCF Yield % is 12.84 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SUN has been successfully added to your 